Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds ESS Inc. Issues Statement On Grizzly Research’s Report

News

ESS Inc. Issues Statement On Grizzly Research’s Report

https://essinc.com/ess-inc-statement-on-grizzly-research-report/

byBenzinga Newsdesk

December 7, 2022

1 minute read

https://essinc.com/ess-inc-statement-on-grizzly-research-report/Â

Wells Fargo Maintains Equal-Weight on RLJ Lodging, Lowers Price Target to $13.5

By Benzinga Newsdesk

August 29, 7:04 AM

Wells Fargo analyst Dori Kesten maintains RLJ Lodging (NYSE:RLJ) with a Equal-Weight and lowers the price target from $15 to $13.5.

RLJ

FDA Grants Lantern Pharma Orphan Drug Designation For Drug Candidate LP-284 In High-Grade B-cell Lymphomas

By Benzinga Newsdesk

November 30, 9:12 AM

The Orphan Drug Designation strengthens LP-284's clinical development path and can provide for additional market exclusivity and commercial protection.Lantern has initiated a first-in-human Phase 1 trial (NCT06132503)

LTRN

Wells Fargo Maintains Overweight on ConocoPhillips, Raises Price Target to $154

By Benzinga Newsdesk

November 4, 11:49 AM

Wells Fargo analyst Roger Read maintains ConocoPhillips (NYSE:COP) with a Overweight and raises the price target from $137 to $154.

COP

Elon Musk Can’t Hold Back Laughter As Jack Dorsey Calls Mark Zuckerberg A ‘B** Simp’ Over Decade-Old Snide Remark About Twitter

By Ananya Gairola

April 12, 6:43 AM

Zuckerberg back in 2013 was frustrated with Twitter's refusal to accept his acquisition offers.

TSLA

ESS Inc. Issues Statement On Grizzly Research’s Report

Related Posts

Wells Fargo Maintains Equal-Weight on RLJ Lodging, Lowers Price Target to $13.5

FDA Grants Lantern Pharma Orphan Drug Designation For Drug Candidate LP-284 In High-Grade B-cell Lymphomas

Wells Fargo Maintains Overweight on ConocoPhillips, Raises Price Target to $154

Elon Musk Can’t Hold Back Laughter As Jack Dorsey Calls Mark Zuckerberg A ‘B** Simp’ Over Decade-Old Snide Remark About Twitter